Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
CryptoLab Signs a Contract to Supply Cutting-Edge Homomorphic Encryption Technology to Macrogen 2024-04-16 20:00
AUO Leads Micro LED Ecosystem Dream Team toward Unlocking New Advances in Diverse Field Applications 2024-04-16 19:00
Wingderm® Shines Bright in the U.S.A., Continuously Expanding the Local Business Network 2024-04-16 17:22
Pre-clinical result of LP-005, a novel bi-functional complement antibody-fusion protein was unveiled by LongBio at WCN2024 2024-04-16 02:00
First patient treated in Actinogen's XanaMIA phase 2b Alzheimer's disease trial 2024-04-15 20:30
Wound Care Plus, LLC Revolutionizes Wound Management with ARANZ Medical's Silhouette Solution 2024-04-15 20:00
GenScript Biotech officially joins SBTi to fulfill its sustainability commitment 2024-04-15 15:04
DIGITAL THERAPEUTICS STARTUP RESPIREE™ ANNOUNCES INCORPORATION IN US WITH RESIDENCY AT JLABS @ SAN FRANCISCO 2024-04-15 14:15
【2024 AACR Late Breaking Research】TransThera announces clinical data of tinengotinib to treat patients with advanced solid tumors harboring actionable FGFR1-3 alterations 2024-04-12 21:00
Empowering Lives with COOLiFY: TORRAS Joins Forces with Autistic Families to Advance Technological Excellence and Foster a Deep Sense of Love and Care 2024-04-11 22:00
Nuevocor Strengthens Leadership Team with Appointment of John Lee as Chief Medical Officer 2024-04-11 14:59
J INTS BIO, AACR 2024 - 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, showing Clinical Benefits in the Ongoing Phase 1 Study 2024-04-11 14:56
ACROBiosystems Launches 3D Organoid Solutions, Propelling New Frontiers in Biotherapeutic Research 2024-04-10 21:00
Tsingke Showcases Cutting-Edge Biologics Solutions at Biologics 2024 2024-04-10 14:19
The Second International Conference on Single-cell and Spatial Omics (TICSSO-2) : showcasing the state-of-the-art bioscience achievements 2024-04-09 23:14
BioCity Announces FDA Clearance of the Investigational New Drug Application for its First-In-Class Antibody Drug Conjugate Targeting Glypican 3 2024-04-09 22:10
Meeting the Future | TIANMA Makes a Strong Appearance at 2024 Embedded World 2024-04-09 22:00
Datasea Announces Intent of its CEO to Purchase Up $3,000,000 of its Common Stock in Open Market Purchases 2024-04-09 22:00
Jacobio Pharma to Present Data of PARP7 Inhibitor and P53 Reactivator at the 2024 AACR Annual Meeting 2024-04-09 19:59
GenFleet Therapeutics Announces Broad-spectrum Activity of GFH547, an Oral panRAS (ON) Inhibitor, and Its Potential to Overcome Resistance against SIIP-based KRAS Inhibitors in Late-breaking Research Abstract of 2024 AACR Annual Meeting 2024-04-09 19:00
1 2 3 4 5 762